|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
CA2526285A1
(en)
|
2003-05-15 |
2004-12-23 |
Arqule, Inc. |
Inhibitors of p38 and methods of using the same
|
|
DE602004017316D1
(de)
*
|
2003-07-24 |
2008-12-04 |
Euro Celtique Sa |
Heteroaryl-tetrahydropyridylverbindungen, die sich für die behandlung bzw. die prävention von schmerzen eignen
|
|
EP1867644B1
(en)
*
|
2003-07-24 |
2009-05-20 |
Euro-Celtique S.A. |
Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
|
|
WO2005016910A1
(ja)
|
2003-08-18 |
2005-02-24 |
Sankio Chemical Co., Ltd. |
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
DE10360745A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7319108B2
(en)
|
2004-01-25 |
2008-01-15 |
Sanofi-Aventis Deutschland Gmbh |
Aryl-substituted heterocycles, process for their preparation and their use as medicaments
|
|
DE102004003812A1
(de)
*
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2006010082A1
(en)
*
|
2004-07-08 |
2006-01-26 |
Arqule, Inc. |
1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CN101084211A
(zh)
*
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为治疗剂的用途
|
|
WO2006038680A1
(ja)
*
|
2004-10-01 |
2006-04-13 |
Banyu Pharmaceutical Co.,Ltd |
２－アリールカルボキサミド－含窒素複素環化合物
|
|
CN101094846A
(zh)
|
2004-10-18 |
2007-12-26 |
伊莱利利公司 |
用作mglur3受体拮抗剂的1－(杂)芳基－3－氨基－吡咯烷衍生物
|
|
EP2258704A1
(en)
|
2004-10-19 |
2010-12-08 |
ArQule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
|
|
DE102004051277A1
(de)
*
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
JPWO2006054793A1
(ja)
*
|
2004-11-19 |
2008-06-05 |
財団法人新産業創造研究機構 |
ベンゾフラン化合物、およびそれを含有してなる医薬組成物
|
|
NZ590148A
(en)
|
2004-12-30 |
2012-04-27 |
Janssen Pharmaceutica Nv |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
EP1846388A4
(en)
*
|
2005-01-25 |
2011-12-07 |
Synta Pharmaceuticals Corp |
THIOPHEN COMPOUNDS FOR IGNITIONS AND THE IMMUNE SYSTEM APPLICATIONS
|
|
ATE429428T1
(de)
|
2005-09-30 |
2009-05-15 |
Hoffmann La Roche |
Indanderivate als antagonisten des mch-rezeptors
|
|
CN101379060B
(zh)
*
|
2006-02-10 |
2012-05-23 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
WO2007093365A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
BRPI0707869A2
(pt)
*
|
2006-02-15 |
2011-05-10 |
Sanofi Aventis |
ariltienopirimidinonas substituÍdas com azaciclil, processo para a sua preparaÇço e seus usos como medicamentos
|
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
CA2649288C
(en)
|
2006-04-19 |
2015-11-24 |
Novartis Ag |
6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
|
|
JP5182088B2
(ja)
|
2006-04-19 |
2013-04-10 |
アステラス製薬株式会社 |
アゾールカルボキサミド誘導体
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
CN103435595A
(zh)
|
2006-05-08 |
2013-12-11 |
阿里亚德医药股份有限公司 |
炔类杂芳基化合物
|
|
US8278307B2
(en)
|
2006-05-08 |
2012-10-02 |
Ariad Pharmaceuticals, Inc. |
Monocyclic Heteroaryl compounds
|
|
EP2061767B1
(de)
|
2006-08-08 |
2014-12-17 |
Sanofi |
Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
|
|
MX2009002019A
(es)
|
2006-08-24 |
2009-03-09 |
Novartis Ag |
Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros.
|
|
WO2008031772A1
(en)
*
|
2006-09-11 |
2008-03-20 |
Glaxo Group Limited |
Azabicyclic compounds as inhibitors of monoamines reuptake
|
|
US20080076770A1
(en)
*
|
2006-09-25 |
2008-03-27 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
|
AR063311A1
(es)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
AU2008205252B2
(en)
*
|
2007-01-09 |
2013-02-21 |
Amgen Inc. |
Bis-aryl amide derivatives useful for the treatment of cancer
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
GB0706793D0
(en)
*
|
2007-04-05 |
2007-05-16 |
Evotec Ag |
Compounds
|
|
ES2536406T3
(es)
*
|
2007-06-08 |
2015-05-25 |
Janssen Pharmaceutica, N.V. |
Derivados de piperidina/piperazina
|
|
EP2152271B1
(en)
|
2007-06-08 |
2015-10-21 |
Janssen Pharmaceutica, N.V. |
Piperidine/piperazine derivatives
|
|
JO2972B1
(en)
|
2007-06-08 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Piperidine / piperazine derivatives
|
|
JP5464709B2
(ja)
|
2007-06-08 |
2014-04-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ピペリジン／ピペラジン誘導体
|
|
TWI452044B
(zh)
|
2007-06-15 |
2014-09-11 |
Mitsubishi Tanabe Pharma Corp |
嗎啉衍生物
|
|
TW200918521A
(en)
*
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
|
SI2203439T1
(sl)
|
2007-09-14 |
2011-05-31 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
|
|
PL2200985T3
(pl)
|
2007-09-14 |
2011-12-30 |
Ortho Mcneil Janssen Pharmaceuticals Inc |
1,3-Dipodstawione-4-(arylo-X-fenylo)-1H-pirydyn-2-ony
|
|
CN101801930B
(zh)
|
2007-09-14 |
2013-01-30 |
奥梅-杨森制药有限公司 |
1,3-二取代的-4-苯基-1h-吡啶-2-酮
|
|
SI2215058T1
(sl)
*
|
2007-10-17 |
2012-03-30 |
Sanofi Sa |
Substituirane N fenil bipirolidin sečnine in njihova terapevtska uporaba
|
|
EP2205558B1
(en)
*
|
2007-10-17 |
2012-07-25 |
Sanofi |
Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators
|
|
SI2212282T1
(sl)
*
|
2007-10-17 |
2012-01-31 |
Sanofi Sa |
Substituirani n-fenil-bipirolidin karboksamidi in njihova terapevtska uporaba
|
|
ES2372332T3
(es)
*
|
2007-10-17 |
2012-01-18 |
Sanofi |
N-fenil-bipirrolidina carboxamidas sustituidas y su uso terapéutico.
|
|
EP2206707B1
(en)
|
2007-10-24 |
2014-07-23 |
Astellas Pharma Inc. |
Azolecarboxamide compound or salt thereof
|
|
CN101861316B
(zh)
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
EP2070925A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel
|
|
EP2070924A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
|
|
EP2070916A1
(de)
|
2007-12-10 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
2-Aryl-thiazol-4-carbonsäureamid-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
|
RU2364597C1
(ru)
*
|
2007-12-14 |
2009-08-20 |
Андрей Александрович Иващенко |
ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ Hh-СИГНАЛЬНОГО КАСКАДА, ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АББЕРАНТНОЙ АКТИВНОСТЬЮ Hh СИГНАЛЬНОЙ СИСТЕМЫ
|
|
PE20100083A1
(es)
*
|
2008-06-05 |
2010-02-17 |
Janssen Pharmaceutica Nv |
Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
CA2737699A1
(en)
*
|
2008-09-16 |
2010-03-25 |
Merck Sharp & Dohme Corp. |
Phthalimide derivative metabotropic glutamate r4 ligands
|
|
JP2012006837A
(ja)
*
|
2008-09-30 |
2012-01-12 |
Mochida Pharmaceut Co Ltd |
２−インドールアクリルアミド類縁体
|
|
WO2010043396A1
(en)
|
2008-10-16 |
2010-04-22 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
CA2743449C
(en)
|
2008-11-12 |
2016-10-18 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
AR074466A1
(es)
*
|
2008-12-05 |
2011-01-19 |
Sanofi Aventis |
Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3.
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
|
JP5642661B2
(ja)
*
|
2009-03-05 |
2014-12-17 |
塩野義製薬株式会社 |
Ｎｐｙｙ５受容体拮抗作用を有するピペリジンおよびピロリジン誘導体
|
|
JP5685181B2
(ja)
*
|
2009-03-05 |
2015-03-18 |
塩野義製薬株式会社 |
Ｎｐｙｙ５受容体拮抗作用を有するシクロヘキサン誘導体
|
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
US9452980B2
(en)
*
|
2009-12-22 |
2016-09-27 |
Hoffmann-La Roche Inc. |
Substituted benzamides
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
EP2569280B1
(en)
*
|
2010-05-11 |
2015-02-25 |
Sanofi |
Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
|
|
EP2569294B1
(en)
*
|
2010-05-11 |
2015-03-11 |
Sanofi |
Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
|
|
WO2011143148A1
(en)
*
|
2010-05-11 |
2011-11-17 |
Sanofi |
Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
|
|
UY33469A
(es)
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
US9271967B2
(en)
|
2010-11-08 |
2016-03-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
US9051265B2
(en)
|
2011-06-06 |
2015-06-09 |
The Scripps Research Institute |
N-benzylindole modulators of PPARG
|
|
US8957093B2
(en)
|
2011-06-06 |
2015-02-17 |
The Scripps Research Institute |
N-biphenylmethylindole modulators of PPARG
|
|
US9309227B2
(en)
|
2011-11-22 |
2016-04-12 |
The Scripps Research Institute |
N-biphenylmethylbenzimidazole modulators of PPARG
|
|
WO2013085957A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
|
|
WO2013085954A1
(en)
|
2011-12-06 |
2013-06-13 |
Janssen Pharmaceutica Nv |
Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
|
|
CN104684906B
(zh)
*
|
2012-05-11 |
2017-06-09 |
艾伯维公司 |
Nampt抑制剂
|
|
EP2914253B1
(en)
*
|
2012-11-05 |
2018-01-03 |
NantBioScience, Inc. |
Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
CN105102448B
(zh)
|
2013-02-28 |
2018-03-06 |
百时美施贵宝公司 |
作为rock1和rock2抑制剂的苯基吡唑衍生物
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
MX386697B
(es)
|
2014-01-21 |
2025-03-19 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
|
|
WO2015161108A1
(en)
|
2014-04-16 |
2015-10-22 |
The Scripps Research Institute |
Pparg modulators for treatment of osteoporosis
|
|
US20170152226A1
(en)
*
|
2014-07-16 |
2017-06-01 |
Novogen Ltd. |
Functionalised and substituted indoles as anti-cancer agents
|
|
JP6633618B2
(ja)
*
|
2014-08-21 |
2020-01-22 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
強力なｒｏｃｋ阻害剤としてのタイドバックのベンズアミド誘導体
|
|
JP2017526706A
(ja)
*
|
2014-09-10 |
2017-09-14 |
エピザイム，インコーポレイティド |
イソオキサゾールカルボキサミド化合物
|
|
HK1257756A1
(zh)
*
|
2015-08-28 |
2019-10-25 |
Glenmark Pharmaceuticals S.A. |
作为RORγ调节剂的新型碳环化合物
|
|
CN108713019B
(zh)
|
2016-03-17 |
2021-06-15 |
豪夫迈·罗氏有限公司 |
具有作为taar的激动剂的活性的5-乙基-4-甲基-吡唑-3-甲酰胺衍生物
|
|
CN108815167B
(zh)
*
|
2017-05-24 |
2021-04-13 |
四川晶华生物科技有限公司 |
一种化合物在制备治疗肿瘤的药物中的用途
|
|
TW202136238A
(zh)
*
|
2020-01-06 |
2021-10-01 |
大陸商廣東東陽光藥業有限公司 |
RORγt抑制劑及其製備方法和用途
|
|
WO2022150962A1
(en)
*
|
2021-01-12 |
2022-07-21 |
Westlake Pharmaceutical (Hangzhou) Co., Ltd. |
Protease inhibitors, preparation, and uses thereof
|
|
CN115160269A
(zh)
*
|
2021-04-02 |
2022-10-11 |
北京大学 |
芳甲酰胺类衍生物作为nmdar的正性变构调节剂
|
|
MX2024008868A
(es)
|
2022-01-18 |
2024-09-23 |
Maze Therapeutics Inc |
Inhibidores de la apolipoproteína l1 (apol1) y métodos de uso.
|